Literature DB >> 33561962

Structural Insights into Ligand-Receptor Interactions Involved in Biased Agonism of G-Protein Coupled Receptors.

Krzysztof Jóźwiak1, Anita Płazińska1.   

Abstract

G protein-coupled receptors (GPCRs) are versatile signaling proteins that mediate complex cellular responses to hormones and neurotransmitters. Ligand directed signaling is observed when agonists, upon binding to the same receptor, trigger significantly different configuration of intracellular events. The current work reviews the structurally defined ligand - receptor interactions that can be related to specific molecular mechanisms of ligand directed signaling across different receptors belonging to class A of GPCRs. Recent advances in GPCR structural biology allow for mapping receptors' binding sites with residues particularly important in recognition of ligands' structural features that are responsible for biased signaling. Various studies show particular role of specific residues lining the extended ligand binding domains, biased agonists may alternatively affect their interhelical interactions and flexibility what can be translated into intracellular loop rearrangements. Studies on opioid and angiotensin receptors indicate importance of residues located deeper within the binding cavity and direct interactions with receptor residues linking the ortosteric ligand binding site with the intracellular transducer binding domain. Collection of results across different receptors may suggest elements of common molecular mechanisms which are responsible for passing alternative signals from biased agonists.

Entities:  

Keywords:  angiotensin receptors; dopaminergic receptors; ligand directed signaling; muscarinic receptors; opioid receptors; serotonin receptors; β-adrenergic receptors

Mesh:

Substances:

Year:  2021        PMID: 33561962      PMCID: PMC7915493          DOI: 10.3390/molecules26040851

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  65 in total

Review 1.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

2.  The effect of stereochemistry on the thermodynamic characteristics of the binding of fenoterol stereoisomers to the beta(2)-adrenoceptor.

Authors:  Krzysztof Jozwiak; Lawrence Toll; Lucita Jimenez; Anthony Yiu-Ho Woo; Rui-Ping Xiao; Irving W Wainer
Journal:  Biochem Pharmacol       Date:  2010-02-06       Impact factor: 5.858

Review 3.  Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective.

Authors:  Jeremy Shonberg; Laura Lopez; Peter J Scammells; Arthur Christopoulos; Ben Capuano; J Robert Lane
Journal:  Med Res Rev       Date:  2014-05-05       Impact factor: 12.944

4.  Histidine 6.55 is a major determinant of ligand-biased signaling in dopamine D2L receptor.

Authors:  Nuska Tschammer; Stefan Bollinger; Terry Kenakin; Peter Gmeiner
Journal:  Mol Pharmacol       Date:  2010-12-16       Impact factor: 4.436

5.  Activation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells.

Authors:  Artur Wnorowski; Mariola Sadowska; Rajib K Paul; Nagendra S Singh; Anna Boguszewska-Czubara; Lucita Jimenez; Kotb Abdelmohsen; Lawrence Toll; Krzysztof Jozwiak; Michel Bernier; Irving W Wainer
Journal:  Cell Signal       Date:  2015-02-20       Impact factor: 4.315

6.  Morphine side effects in beta-arrestin 2 knockout mice.

Authors:  Kirsten M Raehal; Julia K L Walker; Laura M Bohn
Journal:  J Pharmacol Exp Ther       Date:  2005-05-25       Impact factor: 4.030

7.  A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling.

Authors:  James W Wisler; Scott M DeWire; Erin J Whalen; Jonathan D Violin; Matthew T Drake; Seungkirl Ahn; Sudha K Shenoy; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-09       Impact factor: 11.205

Review 8.  Choosing among β-blockers in heart failure patients according to β-receptors' location and functions in the cardiopulmonary system.

Authors:  Gianfranco Sinagra; Ugo Corrà; Mauro Contini; Damiano Magrì; Stefania Paolillo; Pasquale Perrone Filardi; Susanna Sciomer; Roberto Badagliacca; Piergiuseppe Agostoni
Journal:  Pharmacol Res       Date:  2020-03-26       Impact factor: 7.658

Review 9.  GPCR Signaling Regulation: The Role of GRKs and Arrestins.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Front Pharmacol       Date:  2019-02-19       Impact factor: 5.810

Review 10.  Conformational Basis of G Protein-Coupled Receptor Signaling Versatility.

Authors:  Laura M Wingler; Robert J Lefkowitz
Journal:  Trends Cell Biol       Date:  2020-07-02       Impact factor: 20.808

View more
  2 in total

Review 1.  ATRAP, a receptor-interacting modulator of kidney physiology, as a novel player in blood pressure and beyond.

Authors:  Kouichi Tamura; Kengo Azushima; Sho Kinguchi; Hiromichi Wakui; Takahiro Yamaji
Journal:  Hypertens Res       Date:  2021-10-12       Impact factor: 3.872

Review 2.  The Implication of 5-HT Receptor Family Members in Aggression, Depression and Suicide: Similarity and Difference.

Authors:  Nina K Popova; Anton S Tsybko; Vladimir S Naumenko
Journal:  Int J Mol Sci       Date:  2022-08-08       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.